GLSI
Greenwich LifeSciences, Inc.
There isn't enough reported data to score GLSI yet.
GLSI Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
GLSI's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
GLSI PE Valuation
GLSI has no meaningful PE right now: it lost money over the past year.
GLSI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| -- | |
| -- | |
| Limited | |
| High |
Analysts expect GLSI's earnings, revenue and profitability to hold roughly steady.
GLSI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.63 | -$0.26 |
| Q1 2026 | -$1.66 | -$0.39 |
| Q4 2025 | -$1.52 | -$0.31 |
| Q3 2025 | -$1.47 | -$0.68 |
| Q2 2025 | -$1.37 | -$0.59 |
| Q1 2025 | -$1.27 | -$0.56 |
| Q4 2024 | -$1.21 | -$0.52 |
| Q3 2024 | -$0.79 | -$0.08 |
GLSI lost $1.63 per share over the past year, a bigger loss than the year before.
GLSI Quarterly Revenue
GLSI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.9M | +$293.4K |
| Q1 2026 | -$4.7M | -$2.9M |
| Q4 2025 | -$3.2M | -$1.3M |
| Q3 2025 | -$2.7M | -$87.3K |
| Q2 2025 | -$2.2M | -$1.2M |
| Q1 2025 | -$1.8M | -$51.9K |
| Q4 2024 | -$1.9M | +$302K |
| Q3 2024 | -$2.6M | -$783.3K |
GLSI has burned cash in almost every quarter: −$12M over the past year, against −$9M the year before.
GLSI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +56K shares |
| 1 year | +9.4% | +1.3M shares |
| 3 years | +14% | +1.8M shares |
| 5 years | +13% | +1.7M shares |
| Available history | +22% | +2.7M shares |
GLSI has 15M diluted shares, up 9.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $2M |
| Q1 2022 | $5.5M |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
| Q3 2019 | — |
GLSI Net Leverage
GLSI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GLSI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.0 | Neutral |
| Stochastic | 36.6 | Neutral |
GLSI's weekly RSI is 44 (neutral) and its Stochastic is 37 (neutral).
GLSI PE vs Healthcare Sector
GLSI has no meaningful PE right now: it lost money over the past year.
GLSI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.3 | 6.1% below |
| 20 week MA | $16.4 | 7% below |
| 50 week MA | $20.6 | 26% below |
| 100 week MA | $15.7 | 2.4% below |
| 200 week MA | $14.2 | 7.8% above |
GLSI has fallen below most of its moving averages, though it's still 7.8% above its 200-week average.
GLSI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.00 | $39.3 | +686% |
| 2021 | $39.3 | $26.9 | -32% |
| 2022 | $26.9 | $14.6 | -46% |
| 2023 | $14.6 | $10.5 | -28% |
| 2024 | $10.5 | $11.5 | +9.3% |
| 2025 | $11.5 | $20.7 | +80% |
| 2026 YTD | $20.7 | $15.3 | -26% |
GLSI's yearly returns have swung widely, from +686% in 2020 to −46% in 2022. It's down 26% so far in 2026.